Normal
0
false
false
false
EN-US
X-NONE
AR-SA
MicrosoftInternetExplorer4
Argentina is suing an American pharmaceutical company for secretly experimenting drugs with serious side effects on patients at a hospital in the capital, Buenos Aires, Press TV reports.
The legal action against Eli Lilly comes after the company covertly experimented with the dangerous drugs, using the Argentinean patients as guinea pigs.
Argentina-based US drug laboratories are now under close scrutiny after carrying out controversial testing of new medications without acquiring the consent of the patients.
One of such cases involves María Beatriz Carbonne, who was diagnosed and under treatment in a public hospital for mild depression when she was abruptly referred to the renowned German Hospital of Buenos Aires with the pledge that she would receive better, top-notch therapy.
She, however, was not informed of the fact that she would be part of a secret drug experiment for the US pharmaceutical lab.
At the time Eli Lilly was conducting the experiment in Argentina, it was being sued for the exact same illegal procedures in various US states, such as New Jersey and Alaska.
“Eli Lilly was condemned to pay $62 million in the United States and, notwithstanding, they committed the same crime in Argentina with no permits from national authorities,” said Patricia Venega, a lawyer for the Argentinean victims.
Argentinean observers say this serves as a proof that Eli Lilly carried out such experiments in developing nations despite being fully aware of the side effects in a bid to garner some counter evidence to substantiate their case before US courts.
Argentinean authorities are pressing for tougher monitoring of the activities of international laboratories in the country.
MFB/HJL/HRB
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-qformat:yes;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin-top:0in;
mso-para-margin-right:0in;
mso-para-margin-bottom:10.0pt;
mso-para-margin-left:0in;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:"Times New Roman";
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;}